Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$2.08B |
| 2 |
Microsoft
MSFT
|
$699M |
| 3 |
Exxon Mobil
XOM
|
$614M |
| 4 |
Apple
AAPL
|
$587M |
| 5 |
UnitedHealth
UNH
|
$448M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1.1B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$477M |
| 3 |
GE Aerospace
GE
|
$375M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
$271M |
| 5 |
Applied Materials
AMAT
|
$209M |
Sector Composition
| 1 | Technology | 20.72% |
| 2 | Financials | 16.94% |
| 3 | Industrials | 12.29% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Sphere 3D
ANY
$18.3M
| $79.1K | ﹤0.01% |
73,260
-60,344
| -45% | -$65.2K |
|
3277
SurgePays
SURG
$54.1M
| $77.5K | ﹤0.01% |
24,331
+7,998
| +49% | +$25.5K |
|
|
SY
3278
So-Young International
SY
$371M
| $75.2K | ﹤0.01% |
70,575
-15,707
| -18% | -$16.7K |
|
3279
Dominari Holdings
DOMH
$90.9M
| $74.5K | ﹤0.01% |
39,833
+2,457
| +7% | +$4.6K |
|
3280
Invivyd
IVVD
$239M
| $71.1K | ﹤0.01% |
64,525
-1,032
| -2% | -$1.14K |
|
3281
Usio Inc
USIO
$37.4M
| $71K | ﹤0.01% |
46,421
-4
| -0% | -$6 |
|
3282
Copel
ELPC
$6.21B
| $70.9K | ﹤0.01% |
11,920
+198
| +2% | +$1.18K |
|
3283
Mural Oncology
MURA
$35.9M
| $70.8K | ﹤0.01% |
22,563
-16,170
| -42% | -$50.8K |
|
3284
TScan Therapeutics
TCRX
$108M
| $70.5K | ﹤0.01% |
+11,882
| New | +$70.5K |
|
3285
Lightpath Technologies
LPTH
$243M
| $68.7K | ﹤0.01% |
54,543
| – | – |
|
|
VCSA
3286
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $68.7K | ﹤0.01% |
14,099
+2,448
| +21% | +$11.9K |
|
|
LUMO
3287
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $68.6K | ﹤0.01% |
29,587
-30
| -0.1% | -$70 |
|
3288
AYTU BioPharma
AYTU
$20.2M
| $68.5K | ﹤0.01% |
23,551
+8,311
| +55% | +$24.2K |
|
|
LEV
3289
DELISTED
The Lion Electric Company
LEV
| $68.4K | ﹤0.01% |
75,230
| – | – |
|
|
ME
3290
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $68.1K | ﹤0.01% |
8,705
| – | – |
|
3291
SPAR Group
SGRP
$28.2M
| $68K | ﹤0.01% |
+28,210
| New | +$68K |
|
3292
Lightbridge
LTBR
$369M
| $64.2K | ﹤0.01% |
19,038
-17,581
| -48% | -$59.2K |
|
|
IMA
3293
ImageneBio, Inc. Common Stock
IMA
$89M
| $64K | ﹤0.01% |
3,218
| – | – |
|
|
ICAD
3294
DELISTED
iCAD Inc
ICAD
| $63.8K | ﹤0.01% |
49,099
-1,239
| -2% | -$1.61K |
|
3295
Sono-Tek
SOTK
$61.7M
| $62.7K | ﹤0.01% |
16,192
-299
| -2% | -$1.16K |
|
3296
Lisata Therapeutics
LSTA
$18.7M
| $60.2K | ﹤0.01% |
17,336
+5,639
| +48% | +$19.6K |
|
3297
Flexible Solutions
FSI
$120M
| $59.6K | ﹤0.01% |
34,074
-6,173
| -15% | -$10.8K |
|
3298
Acrivon Therapeutics
ACRV
$41.8M
| $58.4K | ﹤0.01% |
+10,066
| New | +$58.4K |
|
3299
Lyell Immunopharma
LYEL
$233M
| $58.1K | ﹤0.01% |
2,005
+1,332
| +198% | +$38.6K |
|
3300
OPAL Fuels
OPAL
$65.5M
| $57.8K | ﹤0.01% |
14,126
-2,722
| -16% | -$11.1K |
|